TrialNature communications2026

A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.

Lauren P Cobb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.